Gilder Gagnon Howe & Co’s KYTHERA BIOPHARMACEUTICALS, INC COM KYTH Stock Holding History

Gilder Gagnon Howe & Co’s Portfolio KYTH Stock Details KYTH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	–	Sell	-27,291	Closed	-$1.02M	–	296
2013 Q4	$1.02M	Sell	27,291 -9,030	-25%	-$375K	0.01%	207
2013 Q3	$1.66M	Buy	+36,321	New	+$1.09M	0.03%	196

Other funds holding KYTH

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Gilder Gagnon Howe & Co's KYTH Position: Q1 2014 in Review

Gilder Gagnon Howe & Co sold out of KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) in Q1 2014, closing a stake of 27,291 shares — an estimated $1.02M sold.

Gilder Gagnon Howe & Co first reported a position in KYTH in Q3 2013 and held it in 2 quarters. The position peaked at $1.66M in Q3 2013. 102 funds tracked by Wall St. Rank hold KYTH as of Q1 2014.

Gilder Gagnon Howe & Co reported no remaining KYTHERA BIOPHARMACEUTICALS, INC COM position as of Q1 2014 after selling out during the quarter.
Gilder Gagnon Howe & Co sold 27,291 KYTHERA BIOPHARMACEUTICALS, INC COM shares in Q1 2014, an estimated $1.02M.
Gilder Gagnon Howe & Co first reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM in Q3 2013 and held it in 2 quarters.
Gilder Gagnon Howe & Co's KYTHERA BIOPHARMACEUTICALS, INC COM position peaked at $1.66M in Q3 2013.
102 funds tracked by Wall St. Rank held KYTHERA BIOPHARMACEUTICALS, INC COM as of Q1 2014.

Based on Gilder Gagnon Howe & Co's 13F filing for Q1 2014, filed 9 May 2014.